{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:15:24Z","timestamp":1773814524340,"version":"3.50.1"},"reference-count":28,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:p> Objective To describe the clinical activities at the Neuroimmunology Clinic of the Universidade Federal de S\u00e3o Paulo (UNIFESP) from 1994 to 2013. Method The final diagnosis of all patients that attended the center was reviewed and established upon specific guidelines for each disease. The number of total appointments and extra clinical activities (reports and prescriptions) were also analyzed, as are part of routine activities. Results 1,599 patients attended the Clinic from 1994 to 2013: 816 with multiple sclerosis (MS), 172 with clinical isolated syndromes, 178 with neuromyelitis optica (NMO), 216 with other demyelinating disease, 20 with metabolic disorder, 42 with a vascular disease and 155 with other or undetermined diagnosis. A mean 219 outpatient visits and 65 extra clinical activities were performed monthly. Conclusion We identified that 15% of patients seen have NMO. As patients with NMO have a more severe disease than MS, this data may be important for planning local health care policies.<\/jats:p>","DOI":"10.1590\/0004-282x20150004","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T20:39:41Z","timestamp":1431117581000},"page":"304-308","source":"Crossref","is-referenced-by-count":9,"title":["The profile of patients followed at the Neuroimmunology Clinic at UNIFESP: 20 years analysis"],"prefix":"10.1590","volume":"73","author":[{"given":"Denis Bernardi","family":"Bichuetti","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra Billi","family":"Falc\u00e3o","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda de Castro","family":"Boulos","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilia Mamprim de","family":"Morais","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Beatriz de Campos","family":"Lotti","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela de Oliveira","family":"Fragomeni","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Fernanda","family":"Campos","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilton Amorim de","family":"Souza","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enedina Maria Lobato","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3111\/13696998.2013.778268","article-title":"The cost burden of multiple sclerosis in the United States: a systematic review of the literature","volume":"16","author":"Adelman G","year":"2013","journal-title":"J Med Econ"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","article-title":"Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders","volume":"84","author":"Jacob A","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey","volume":"46","author":"Lublin FD","year":"1996","journal-title":"Neurology"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/01.wnl.0000254502.87233.9a","article-title":"A secondary progressive clinical course is uncommon in neuromyelitis optica","volume":"68","author":"Wingerchuk DM","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1352458508101935","article-title":"Neuromyelitis optica in Brazil: a study on clinical and prognostic factors","volume":"15","author":"Bichuetti DB","year":"2009","journal-title":"Mult Scler"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman CH","year":"2011","journal-title":"Ann Neurol"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk DM","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.mcna.2008.09.014","article-title":"Multiple sclerosis","volume":"93","author":"Courtney AM","year":"2009","journal-title":"Med Clin North Am"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.wco.0000227033.47458.82","article-title":"Epidemiology and natural history of multiple sclerosis: new insights","volume":"19","author":"Kantarci O","year":"2006","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0404.2001.00372.x","article-title":"The prevalence of multiple sclerosis in the city of Sao Paulo, Brazil, 1997","volume":"104","author":"Callegaro D","year":"2001","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1590\/S0004-282X2012000200006","article-title":"The prevalence of multiple sclerosis in Belo Horizonte, Brazil","volume":"70","author":"Lana-Peixoto MA","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/0004-282X20130020","article-title":"Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease","volume":"71","author":"Bichuetti DB","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1352458509350741","article-title":"HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis","volume":"16","author":"Brum DG","year":"2010","journal-title":"Mult Scler"},{"issue":"3","key":"ref14","article-title":"European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil","volume":"8","author":"Brum DG","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/1352458510374340","article-title":"HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica","volume":"16","author":"Matiello M","year":"2010","journal-title":"Mult Scler"},{"key":"ref16","series-title":"Atlas: multiple sclerosis resources in the world 2008","year":"2008"},{"key":"ref17","article-title":"Portaria n\u00ba 1.323, de 25 de novembro de 2013. Aprova o protocolo cl\u00ednico e diretrizes terap\u00eauticas da esclerose m\u00faltipla","year":"2013","journal-title":"Di\u00e1rio Oficial da Uni\u00e3o"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller DH","year":"2008","journal-title":"Mult Scler"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk DM","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst C","year":"2014","journal-title":"J Neurol"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp LB","year":"2013","journal-title":"Mult Scler"},{"issue":"5","key":"ref22","first-page":"291","article-title":"Late onset multiple sclerosis","volume":"26","author":"Arias M","year":"2011","journal-title":"Neurologia"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/WCO.0b013e328346bf66","article-title":"Multiple sclerosis: current treatment algorithms","volume":"24","author":"R\u00edo J","year":"2011","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneurol.2012.545","article-title":"Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients","volume":"69","author":"Bichuetti DB","year":"2012","journal-title":"Arch Neurol"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P04.141","article-title":"Treatment of neuromyelitis optica with intravenous immunoglobulin: report of 8 Patients","volume":"78","author":"Bichuetti DB","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archneurol.2010.203","article-title":"Neuromyelitis optica treatment: analysis of 36 patients","volume":"67","author":"Bichuetti DB","year":"2010","journal-title":"Arch Neurol"},{"key":"ref27","author":"Oliveira EML","year":"2006"},{"key":"ref28","article-title":"Clinical spectrum of diagnoses in children referred for evaluation of acquired CNS demyelinating disorders including pediatric multiple sclerosis","volume":"62","author":"Belman A","year":"2007","journal-title":"Ann Neurol"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v73n4\/0004-282X-anp-73-4-0304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T02:48:44Z","timestamp":1495507724000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2015000400304&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0004-282X2015000400304"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20150004","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}